Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alemtuzumab + CHOP-14 in Elderly PTCL
NCT00725231Phase 3Unknown
- Sponsor
- Georg-August-Universität Göttingen
- Start
- Feb 2008
- Primary completion
- Mar 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of alemtuzumab in peripheral T-cell lymphoma (PTCL), sponsored by Georg-August-Universität Göttingen. Status: unknown.
02
Drugs
alemtuzumab
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT00725231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00725231.